Intercept Pharmaceuticals Stock News

Q1 2020 Intercept Pharmaceuticals Inc Earnings Call

NEW YORK, NY / ACCESSWIRE / June 11, 2020 / Pomerantz LLP is investigating claims on behalf of investors of Intercept Pharmaceuticals, Inc. ("Intercept" or the "Company") (ICPT). Such investors are a

Intercept (ICPT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Regulatory News: IMPLANET (Euronext Growth : ALIMP, FR0013470168, eligible for PEA-PME equity savings plans) (Paris:ALIMP), a medical technology compa

NEW YORK, June 08, Jun 08, 2020 (GLOBE NEWSWIRE via COMTEX) -- Pomerantz LLP is investigating claims on behalf of investors of Intercept Pharmaceuticals,...

Pomerantz LLP is investigating claims on behalf of investors of  Intercept Pharmaceuticals, Inc. (“Intercept” or the “Company”) (ICPT). Such investors are advised to contact Robert S. Willou

Living as an Asian American right now in the United States can be absolutely harrowing. While racial discrimination against Asians and…

Jun 07, 2020 (CDN Newswire via Comtex) -- Global Obeticholic Acid Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2026 designed by a...

Intercept is ahead of a potential FDA approval that could lead to a market opportunity worth billions of dollars. However, the stock is sharply down this year a

Upgrades * For Kontoor Brands Inc (NYSE: KTB), Susquehanna upgraded the stock from Neutral to Positive. Interestingly, in the first quarter, Kontoor Brands's EPS was $0.27. The stock has a 52-week-h

La empresa pública pretende mejorar la seguridad de los cruces de vías al mismo nivel en los apeaderos de Araia, Alegría, Nanclares de la Oca e Iñarratxu

NEW YORK, NY / ACCESSWIRE / June 3, 2020 / Pomerantz LLP is investigating claims on behalf of investors of Intercept Pharmaceuticals, Inc. ("Intercept" or the "Company") (ICPT). Such investors are ad